VIRACTA THERAPEUTICS INC SNSS
COM · Common Stock · CUSIP 92765F108 · ISIN US92765F1084
0
institutional holders
-7 vs Q1 2025
—reported value*
0 new
0 added
0 reduced
7 sold out
net sold ≈ $3.8k (-172.2k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 59 |
| Q4 2022 | 57 |
| Q1 2023 | 49 |
| Q2 2023 | 42 |
| Q3 2023 | 43 |
| Q4 2023 | 43 |
| Q1 2024 | 41 |
| Q2 2024 | 41 |
| Q3 2024 | 39 |
| Q4 2024 | 33 |
| Q1 2025 | 7 |
| Q2 2025 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2023 | 16 | 15 |
| Q4 2023 | 15 | 13 |
| Q1 2024 | 13 | 12 |
| Q2 2024 | 9 | 11 |
| Q3 2024 | 16 | 16 |
| Q4 2024 | 10 | 16 |
| Q1 2025 | 3 | 27 |
| Q2 2025 | 0 | 7 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2024 | $0 | $0 | — |
| Q4 2024 | $290 | $0 | 0.00 |
| Q1 2025 | $0 | $0 | — |
| Q2 2025 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| XTX Topco Ltd | Sold out | -93.4k |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | Sold out | -43.0k |
| WealthTrust Axiom LLC | Sold out | -16.4k |
| Baader Bank Aktiengesellschaft | Sold out | -15.3k |
| RP Management, LLC | Sold out | -3.7k |
| SIMPLEX TRADING, LLC | Sold out | -400 |
| Parallel Advisors, LLC | Sold out | -8 |
Holders, Q2 2025
| Manager | Shares | Change |
|---|